The WHO issued new guidelines endorsing GLP-1 receptor agonists for the long-term treatment of obesity in adults. GLP-1 drugs must be combined with counseling on behavioral and lifestyle changes, the ...

The World Health Organization (WHO) has recommended the use of GLP-1 medications as part of treatment programs to help people manage obesity. In a new guideline published in JAMA, WHO officials said ...

The World Health Organization is officially backing popular weight-loss drugs like Ozempic and Wegovy. The WHO published new guidelines about glucagon-like peptide-1 (GLP-1) medications in the medical ...

New guidelines from the World Health Organization (WHO) recommend using GLP-1 medications to help manage obesity. The agency said the weight-loss drugs should be used in conjunction with a healthy ...